See more : NYOCOR Co., Ltd. (600821.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Guizhou Salvage Pharmaceutical Co.,Ltd. (600227.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guizhou Salvage Pharmaceutical Co.,Ltd., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
You may be interested
- Lazard Growth Acquisition Corp. I (LGAC) Income Statement Analysis – Financial Results
- Boston Sand & Gravel Co. (BSND) Income Statement Analysis – Financial Results
- Boomer Holdings Inc. (BOMH) Income Statement Analysis – Financial Results
- LIC Housing Finance Limited (LICHSGFIN.NS) Income Statement Analysis – Financial Results
- Oisix ra daichi Inc. (3182.T) Income Statement Analysis – Financial Results
Guizhou Salvage Pharmaceutical Co.,Ltd. (600227.SS)
About Guizhou Salvage Pharmaceutical Co.,Ltd.
Guizhou Salvage Pharmaceutical Co.,Ltd. produces and sells urea and methanol in China. The company offers urea fertilizers under the Chi brand; methanol products; and ammonium sulfate, chlorine, and potassium sulfate fertilizers. It also produces and sells medicines, medical devices, and health products for diabetes, cardiovascular, skin disease, gynecology, respiratory tract, digestive system, endocrine, mental nerve, heart, kidney, blood system, circulatory system, and nervous system areas. The company was formerly known as Guizhou Chitianhua Co., Ltd. Guizhou Salvage Pharmaceutical Co.,Ltd. was founded in 1998 and is based in Guiyang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.25B | 2.52B | 2.18B | 1.93B | 2.03B | 2.43B | 1.69B | 2.86B | 2.76B | 3.29B | 4.15B | 3.50B | 1.96B | 1.33B | 1.11B | 1.15B | 1.11B | 852.92M | 874.23M | 731.49M | 589.47M | 659.39M | 630.64M | 600.87M | 598.80M | 621.80M | 582.06M | 562.60M |
| Cost of Revenue | 2.07B | 2.37B | 1.76B | 1.32B | 1.54B | 1.58B | 1.21B | 2.32B | 2.52B | 3.32B | 3.63B | 3.11B | 1.54B | 967.32M | 647.21M | 690.06M | 687.53M | 557.85M | 566.09M | 520.88M | 472.06M | 550.72M | 590.24M | 528.47M | 498.92M | 512.32M | 456.62M | 442.29M |
| Gross Profit | 177.30M | 145.57M | 421.68M | 604.44M | 487.28M | 846.05M | 478.50M | 534.95M | 244.78M | -38.28M | 521.40M | 390.29M | 423.09M | 362.01M | 464.96M | 458.10M | 426.17M | 295.07M | 308.14M | 210.61M | 117.41M | 108.68M | 40.41M | 72.40M | 99.88M | 109.48M | 125.44M | 120.30M |
| Gross Profit Ratio | 7.89% | 5.78% | 19.33% | 31.37% | 24.05% | 34.81% | 28.26% | 18.72% | 8.86% | -1.16% | 12.56% | 11.14% | 21.58% | 27.23% | 41.81% | 39.90% | 38.27% | 34.59% | 35.25% | 28.79% | 19.92% | 16.48% | 6.41% | 12.05% | 16.68% | 17.61% | 21.55% | 21.38% |
| Research & Development | 102.59M | 96.69M | 95.63M | 72.43M | 73.48M | 56.40M | 26.14M | 28.20M | 85.03K | 4.55M | 11.44M | 5.14M | 4.15M | 2.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 109.69M | 45.23M | 30.96M | 45.38M | 27.48M | 24.71M | 74.87M | 58.57M | 37.82M | 45.53M | 55.61M | 98.04M | 50.02M | 55.39M | 160.23M | 153.28M | 139.23M | 128.37M | 77.43M | 57.19M | 45.89M | 42.25M | 25.94M | 26.56M | 23.74M | 24.58M | 27.11M | 27.35M |
| Selling & Marketing | 51.03M | 74.23M | 90.22M | 124.94M | 194.16M | 253.22M | 195.58M | 227.66M | 77.92M | 165.41M | 206.37M | 130.54M | 84.76M | 70.74M | 69.76M | 84.39M | 57.68M | 6.49M | 12.93M | 8.56M | 9.80M | 8.55M | 8.43M | 5.36M | 6.32M | 4.88M | 10.75M | 15.68M |
| SG&A | 160.72M | 119.47M | 121.17M | 170.32M | 221.64M | 277.94M | 270.45M | 286.23M | 115.74M | 210.94M | 261.99M | 228.58M | 134.78M | 126.13M | 229.99M | 237.67M | 196.90M | 134.87M | 90.36M | 65.75M | 55.68M | 50.80M | 34.37M | 31.91M | 30.06M | 29.47M | 37.86M | 43.04M |
| Other Expenses | 46.40M | 86.41M | 135.18M | 140.92M | 124.00M | -30.55M | 22.90M | -7.17M | 22.40M | 9.85M | 17.34M | 17.39M | 3.18M | 20.70M | 4.99M | 25.22M | -3.41M | 33.87M | 24.36M | 5.31M | 4.59M | 6.19M | 4.24M | 5.58M | 49.90K | -1.83M | -2.36M | -820.51K |
| Operating Expenses | 309.72M | 302.56M | 351.98M | 383.68M | 419.11M | 459.91M | 414.26M | 524.27M | 267.30M | 375.81M | 432.61M | 381.55M | 261.34M | 240.11M | 231.99M | 238.28M | 198.01M | 135.26M | 95.04M | 68.41M | 56.32M | 52.41M | 34.37M | 31.91M | 30.06M | 30.87M | 41.09M | 45.86M |
| Cost & Expenses | 2.38B | 2.67B | 2.11B | 1.71B | 1.96B | 2.04B | 1.63B | 2.85B | 2.78B | 3.70B | 4.06B | 3.50B | 1.80B | 1.21B | 879.20M | 928.34M | 885.53M | 693.12M | 661.13M | 589.29M | 528.38M | 603.12M | 624.60M | 560.38M | 528.98M | 543.19M | 497.71M | 488.15M |
| Interest Income | 1.89M | 570.82K | 603.34K | 1.25M | 3.30M | 2.66M | 4.67M | 4.03M | 7.72M | 5.64M | 10.68M | 11.39M | 4.61M | 9.58M | 0.00 | -0.41 | 2.10M | 5.84M | 6.23M | 4.42M | 4.15M | 4.03M | 2.37M | 2.16M | -0.29 | -0.34 | -0.36 | -0.83 |
| Interest Expense | 44.45M | 20.03M | 19.56M | 31.01M | 44.48M | 71.72M | 62.47M | 150.53M | 155.79M | 187.72M | 210.19M | 169.69M | 3.69M | 10.38M | 40.40M | 24.24M | 93.00 | -3.25K | 30.08K | 19.83K | 22.39K | 59.94K | 732.20K | 329.26K | 4.06M | 6.87M | 4.41M | 3.19M |
| Depreciation & Amortization | 199.40M | 179.22M | 173.14M | 173.39M | 264.06M | 285.42M | 284.55M | 313.77M | 317.76M | 284.83M | 286.92M | 241.11M | 51.00M | 88.51M | 81.14M | 78.80M | 72.75M | 78.41M | 30.07M | 22.48M | 26.61M | 23.08M | 24.19M | 611.84K | 26.59M | 6.81M | 4.30M | 2.27M |
| EBITDA | 97.91M | -156.37M | 127.93M | 267.04M | -1.39B | 585.20M | 404.76M | 99.47M | 533.35M | -78.59M | 548.56M | 401.24M | 178.76M | 265.23M | 314.12M | 324.91M | 307.65M | 285.92M | 250.82M | 152.38M | 87.71M | 95.51M | 67.05M | 77.68M | 96.40M | 85.42M | 84.35M | 74.44M |
| EBITDA Ratio | 4.36% | 0.20% | 10.83% | 19.31% | 15.95% | 26.77% | 25.96% | 11.60% | 20.43% | -1.22% | 13.98% | 12.01% | 11.34% | 18.16% | 30.86% | 25.99% | 27.23% | 32.85% | 28.69% | 20.83% | 14.88% | 14.48% | 10.63% | 13.03% | 16.14% | 13.74% | 14.49% | 13.23% |
| Operating Income | -132.42M | -172.87M | 56.75M | 200.19M | 60.32M | 266.13M | 45.56M | -309.35M | 36.28M | -562.54M | 34.21M | -35.33M | 121.03M | 145.11M | 166.93M | 196.66M | 232.14M | 168.58M | 198.65M | 125.71M | 77.59M | 66.44M | 38.06M | 72.36M | 65.63M | 71.88M | 80.05M | 72.17M |
| Operating Income Ratio | -5.90% | -6.87% | 2.60% | 10.39% | 2.98% | 10.95% | 2.69% | -10.83% | 1.31% | -17.12% | 0.82% | -1.01% | 6.17% | 10.92% | 15.01% | 17.13% | 20.84% | 19.76% | 22.72% | 17.19% | 13.16% | 10.08% | 6.03% | 12.04% | 10.96% | 11.56% | 13.75% | 12.83% |
| Total Other Income/Expenses | -13.51M | -1.79M | -126.96M | -19.62M | -1.77B | -83.56M | 22.90M | -7.33M | 23.31M | 6.33M | 17.20M | 17.39M | -36.50M | 20.70M | -61.97M | 25.22M | -2.49M | -3.32M | 5.38M | -13.43M | 3.95M | 5.93M | 4.07M | 4.38M | -79.35K | -1.96M | -2.47M | -1.74M |
| Income Before Tax | -145.93M | -366.87M | -70.21M | 59.05M | -1.71B | 235.58M | 68.46M | -316.69M | 58.68M | -556.20M | 51.42M | -17.93M | 123.65M | 165.81M | 171.92M | 221.88M | 228.73M | 201.74M | 220.75M | 129.90M | 81.54M | 72.36M | 42.13M | 76.74M | 65.56M | 69.92M | 77.58M | 70.43M |
| Income Before Tax Ratio | -6.50% | -14.57% | -3.22% | 3.06% | -84.23% | 9.69% | 4.04% | -11.08% | 2.12% | -16.92% | 1.24% | -0.51% | 6.31% | 12.47% | 15.46% | 19.32% | 20.54% | 23.65% | 25.25% | 17.76% | 13.83% | 10.97% | 6.68% | 12.77% | 10.95% | 11.24% | 13.33% | 12.52% |
| Income Tax Expense | -21.95M | 4.61M | -13.56M | 6.67M | 5.12M | 39.06M | 31.75M | 20.78M | 17.07M | 8.09M | 31.98M | 22.38M | 30.64M | 32.92M | 28.81M | 53.49M | 34.56M | 31.11M | 45.67M | 24.28M | 10.19M | 11.11M | 4.61M | 11.61M | 9.87M | 23.07M | 25.60M | 23.24M |
| Net Income | -119.27M | -371.48M | -56.64M | 55.61M | -1.71B | 197.33M | 36.71M | -349.53M | 20.25M | -574.70M | 11.07M | 35.29M | 92.85M | 125.30M | 137.42M | 165.88M | 192.21M | 170.63M | 175.09M | 105.61M | 71.35M | 61.26M | 37.52M | 65.13M | 55.69M | 46.84M | 51.98M | 47.19M |
| Net Income Ratio | -5.31% | -14.76% | -2.60% | 2.89% | -84.49% | 8.12% | 2.17% | -12.23% | 0.73% | -17.49% | 0.27% | 1.01% | 4.74% | 9.43% | 12.36% | 14.45% | 17.26% | 20.00% | 20.03% | 14.44% | 12.10% | 9.29% | 5.95% | 10.84% | 9.30% | 7.53% | 8.93% | 8.39% |
| EPS | -0.07 | -0.22 | -0.03 | 0.03 | -1.01 | 0.12 | 0.02 | -0.22 | 0.09 | -0.60 | 0.01 | 0.04 | 0.10 | 0.14 | 0.20 | 0.29 | 0.58 | 0.27 | 0.28 | 0.17 | 0.11 | 0.10 | 0.06 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 |
| EPS Diluted | -0.07 | -0.22 | -0.03 | 0.03 | -1.01 | 0.11 | 0.02 | -0.22 | 0.09 | -0.60 | 0.01 | 0.04 | 0.10 | 0.14 | 0.19 | 0.28 | 0.53 | 0.27 | 0.28 | 0.17 | 0.11 | 0.10 | 0.06 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 |
| Weighted Avg Shares Out | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B | 1.74B | 1.57B | 1.41B | 950.39M | 948.99M | 951.22M | 947.49M | 921.31M | 687.09M | 624.49M | 345.90M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M |
| Weighted Avg Shares Out (Dil) | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B | 1.73B | 1.74B | 1.57B | 1.41B | 950.39M | 948.99M | 951.22M | 947.49M | 921.31M | 723.25M | 635.44M | 374.72M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M | 624.55M |
No news found for: 600227.SS
Source: https://incomestatements.info
Category: Stock Reports